No Data
No Data
Bristol Myers Lung Cancer Drug Krazati Succeeds in Late-stage Trial
Express News | Krazati (Adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients With Pretreated Locally Advanced or Metastatic Krasg12C-Mutated Non-Small Cell Lung Cancer
Immunocore Touts Updated Phase 1 Results for Melanoma Asset Brenetafusp
Express News | NYSE Order Imbalance 1870132.0 Shares on Sell Side
FDA Expands Approval For Bristol Myers Squibb's Breyanzi, Making CAR T Cell Therapy Available For Broadest Range Of B-Cell Malignancies
On Thursday, the FDA approved Bristol Myers Squibb Co's (NYSE:BMY) Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for relapsed or refrac
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
No Data
Moomoo Lily : Thank you for your support